Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva Stock Soars After Reaching $4.25 Billion Opioid Settlement | Barron's
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva made smart decision to move to us: Allergan CEO
Teva CEO Schultz likely won't renew employment contract: reports
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Teva looks to amp up research collaborations, CEO says
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | The Seattle Times
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Allergan to own 10% stake in Teva
New York could get $524M under opioid settlements with Teva - ABC News
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel - YouTube
TEVA Plunges on Q1 Results - TipRanks.com
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Unveils Spring 2023 Collection | | news-journal.com
Teva CEO Richard Francis, after 120 days at the helm, preps grand strategic reveal
Teva Zymic
